These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28988524)

  • 21. Obesity and contraception: emerging issues.
    Murthy AS
    Semin Reprod Med; 2010 Mar; 28(2):156-63. PubMed ID: 20352564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Weight gain and progestin-only contraceptives: more concern than evidence].
    Camain JY; Renteria SC; von Elm E
    Rev Med Suisse; 2011 Oct; 7(314):2090-2, 2094-5. PubMed ID: 22141308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Choice of contraceptives.
    Med Lett Drugs Ther; 2015 Sep; 57(1477):127-32. PubMed ID: 26353044
    [No Abstract]   [Full Text] [Related]  

  • 24. European society of contraception statement on contraception in obese women.
    Merki-Feld GS; Skouby S; Serfaty D; Lech M; Bitzer J; Crosignani PG; Cagnacci A; Sitruk-Ware R
    Eur J Contracept Reprod Health Care; 2015 Feb; 20(1):19-28. PubMed ID: 25380138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Missed hormonal contraceptives: new recommendations.
    Guilbert E; Black A; Dunn S; Senikas V; ;
    J Obstet Gynaecol Can; 2008 Nov; 30(11):1050-1062. PubMed ID: 19126288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Weight gain due to hormonal contraception: myth or truth?].
    Häni D; Imthurn B; Merki-Feld GS
    Gynakol Geburtshilfliche Rundsch; 2009; 49(2):87-93. PubMed ID: 19346753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormonal contraceptives for contraception in overweight or obese women.
    Obstet Gynecol; 2010 Nov; 116(5):1206-7. PubMed ID: 20966707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Vascular disease and hormonal treatment--epidemiology].
    Vessey MP
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):121-6. PubMed ID: 12280197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Drug and food interactions with contraceptives: CNGOF Contraception Guidelines].
    Bernier M; Jonville-Bera AP
    Gynecol Obstet Fertil Senol; 2018 Dec; 46(12):786-791. PubMed ID: 30385357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombotic risk of contraceptive transdermal patches and the contraceptive vaginal ring.
    Prescrire Int; 2013 Nov; 22(143):266, 268-9. PubMed ID: 24427838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormonal contraception and lactation.
    Kelsey JJ
    J Hum Lact; 1996 Dec; 12(4):315-8. PubMed ID: 9025449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obesity and hormonal contraception: an overview and a clinician's practical guide.
    Cipriani S; Todisco T; Scavello I; Di Stasi V; Maseroli E; Vignozzi L
    Eat Weight Disord; 2020 Oct; 25(5):1129-1140. PubMed ID: 31515745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Managing adverse effects of hormonal contraceptives.
    Grossman Barr N
    Am Fam Physician; 2010 Dec; 82(12):1499-506. PubMed ID: 21166370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hormonal contraception].
    Van Cauwenberge JR
    Rev Med Liege; 1992 May; 47(5):221-36. PubMed ID: 1604074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and tolerability of a new low-dose contraceptive patch in obese and nonobese women.
    Kaunitz AM; Archer DF; Mishell DR; Foegh M
    Am J Obstet Gynecol; 2015 Mar; 212(3):318.e1-8. PubMed ID: 25220709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination contraceptives: effects on weight.
    Gallo MF; Lopez LM; Grimes DA; Schulz KF; Helmerhorst FM
    Cochrane Database Syst Rev; 2008 Oct; (4):CD003987. PubMed ID: 18843652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study design to evaluate the safety and effectiveness of hormonal contraception for women.
    Kapp N; Curtis KM; Borgatta L
    Clin Obstet Gynecol; 2007 Dec; 50(4):850-67. PubMed ID: 17982328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormonal contraception.
    Baird DT; Glasier AF
    N Engl J Med; 1993 May; 328(21):1543-9. PubMed ID: 8479492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contraceptive safety among women with cystic fibrosis: a systematic review.
    Whiteman MK; Oduyebo T; Zapata LB; Walker S; Curtis KM
    Contraception; 2016 Dec; 94(6):621-629. PubMed ID: 27287694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of hormonal contraceptives in an institutional setting: reasons for use, consent and safety in women with psychiatric and intellectual disabilities.
    Egan TM; Siegert RJ; Fairley NA
    N Z Med J; 1993 Aug; 106(961):338-41. PubMed ID: 8341476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.